THIRD SUPPLEMENTAL INDENTUREThird Supplemental Indenture • August 16th, 2016 • 21st Century Oncology Holdings, Inc. • Services-offices & clinics of doctors of medicine • New York
This Third Supplemental Indenture, dated as of August 16, 2016 (this “Third Supplemental Indenture”), is by and among 21st Century Oncology, Inc., a Florida corporation (the “Issuer,” which term includes its successors and assigns), the Guarantors (as defined in the Indenture (as defined below)) and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”) under the Indenture. Capitalized terms used and not defined herein shall have the same meanings given in the Indenture unless otherwise indicated.
AMENDMENT NO. 2 AND WAIVERCredit Agreement • August 16th, 2016 • 21st Century Oncology Holdings, Inc. • Services-offices & clinics of doctors of medicine • New York
This Amendment No. 2 and Waiver, dated as of August 15, 2016 (this “Amendment”), with respect to that certain credit agreement, dated as of April 30, 2015, among 21st Century Oncology, Inc., a Florida corporation (“Borrower”), 21st Century Oncology Holdings, Inc., a Delaware corporation (“Holdings”), the institutions from time to time party thereto as lenders, Morgan Stanley Senior Funding, Inc., as Administrative Agent and the other agents and arrangers named therein (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), is entered into among Borrower, Holdings, the other Loan Parties and the Required Lenders. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.
